Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arres...( SAN DIEGO Dec. 5 /- Cardium Therapeut...),Health

SAN DIEGO, Dec. 5 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Alternext: CXM) and its operating unit InnerCool Therapies today reported on New York City's adoption of procedures designed to promote temperature modulation therapy for cardiac arrest patients, as featured in an article in The New York Times. The article, "City Pushes Cooling Therapy," dated December 4, 2008, reports that New York City ambulances will now be required to transport cardiac arrest patients to hospitals using therapeutic cooling. The New York City Fire Department has sent letters to hospital executives informing them of the new guidelines which will become effective January 1, 2009. As reported, New York City is now part of a growing list of major U.S. cities that are adopting such cooling protocols, including Miami, Boston, Seattle and Houston, as well as European cities such as Vienna and London. The emerging protocols and guidelines are generally intended to require emergency vehicles to transport cardiac arrest patients to hospitals and resuscitation centers with therapeutic cooling systems, effectively bypassing hospitals that do not establish therapeutic cooling programs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

Temperature modulation therapy to safely and effectively cool patients represents an important new tool that is beginning to be utilized for protecting the brain from ischemia, especially in post-cardiac arrest patients who are at higher risk of brain tissue damage due to the prolonged lack of blood flow. With the increase in survival of cardiac arrest victims resulting from the advent of automated external defibrillators, cooling patients is the next logical therapeutic approach especially in light of the large body of supporting scientific literature, and guidelines issued by the American
'/>"/>